According to Summit Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.62 B. a decrease over its 2022 earnings that were of -$78.79 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.62 B | 680.54% |
2022 | -$78.79 M | -11.08% |
2021 | -$88.61 M | |
2018 | -$3.9 M | -88% |
2017 | -$32.49 M | -27.86% |
2016 | -$45.04 M | 7.59% |
2015 | -$41.86 M | 30.5% |
2014 | -$32.08 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | -$0.53 B | -15.42% | ๐บ๐ธ USA |
Merrimack Pharmaceuticals MACK | -$2.18 M | -99.65% | ๐บ๐ธ USA |
Coherus BioSciences
CHRS | -$0.2 B | -67.85% | ๐บ๐ธ USA |
Arena Pharmaceuticals
ARNA | -$0.63 B | 1.95% | ๐บ๐ธ USA |